Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/gt20029-china-phase-ii-trial-for-aga-reached-primary-endpoint-302122889.html
https://www.prnewswire.com/news-releases/study-of-kintors-c-myc-degrader-published-in-subsidiary-journal-of-nature-302088904.html
https://www.prnewswire.com/news-releases/kintor-pharma-announces-the-approval-for-phase-ii-clinical-trial-of-hedgehogsmo-inhibitor-gt1708f-for-treatment-of-ipf-in-china-301953381.html
https://www.prnewswire.com/news-releases/kintor-pharma-announces-completion-of-patient-enrollment-in-phase-ii-clinical-trial-of-gt20029-for-treatment-of-androgenetic-alopecia-in-china-301906583.html
https://www.indianpharmapost.com/news/kintor-pharma-completes-first-patient-enrollment-in-long-term-safety-phase-iii-trial-of-kx-826-14409
https://www.clinicaltrialsarena.com/news/kintor-androgenetic-alopecia-kx-826/
https://www.prnewswire.com/news-releases/kintor-pharma-announces-2022-annual-results-and-recent-business-progress-301786222.html
https://www.prnewswire.com/news-releases/kintor-pharma-announces-completion-of-subject-enrollment-in-phase-iii-clinical-trial-of-kx-826-for-treatment-of-male-androgenetic-alopecia-in-china-301783455.html
https://www.prnewswire.com/news-releases/kintor-pharmas-kx-826-and-gt20029-for-treatment-of-androgenetic-alopecia-aga-and-acne-presented-at-aad-2023-301777019.html
https://www.clinicaltrialsarena.com/news/kintor-androgenetic-alopecia-therapy/